Erratum: GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils

被引：0

作者：

Nariman A B Balenga

Elma Aflaki

Julia Kargl

Wolfgang Platzer

Ralf Schröder

Stefanie Blättermann

Evi Kostenis

Andrew J Brown

Akos Heinemann

Maria Waldhoer

机构：

[1] Institute of Experimental and Clinical Pharmacology,Department of Screening and Compound Profiling

[2] Medical University of Graz,undefined

[3] Institute of Molecular Biology and Biochemistry,undefined

[4] Medical University of Graz,undefined

[5] Section Molecular,undefined

[6] Cellular and Pharmacobiology,undefined

[7] Institute for Pharmaceutical Biology,undefined

[8] University of Bonn,undefined

[9] GlaxoSmithKline,undefined

[10] Medicines Research Centre,undefined

来源：

Cell Research | 2011年 / 21卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Correction to: Cell Research (2011) 21:1452-1469. doi:10.1038/cr.2011.60; published online 5 April 2011 The authors apologize for the wrong β-actin blot in Figure 4Ai. The Figure 4Ai with the correct β-actin blot is as follows: The authors would also like to update the current addresses for two of the authors in this corrigendum.

引用

页码：1641 / 1641

共 50 条

[21] The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55
Sharir, Haleli
Console-Bram, Linda
Mundy, Christina
Popoff, Steven N.
Kapur, Ankur
Abood, Mary E.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 (04) : 856 - 865
[22] The putative cannabinoid receptor GPR55 participates in the control of cancer cell proliferation
Andradas, C.
Caffarel, M. M.
Salazar, M.
Perez-Gomez, E.
Lorente, M.
Velasco, G.
Guzman, M.
Sanchez, C.
EJC SUPPLEMENTS, 2010, 8 (05): : 91 - 91
[23] GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, Jane E.
Jensen, Jill B.
Chen, Huei-Ying
Lu, Hui-Chen
Hille, Bertil
Mackie, Ken
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (07) : 2699 - 2704
[24] The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
Kargl, Julia
Balenga, Nariman
Parzmair, Gerald P.
Brown, Andrew J.
Heinemann, Akos
Waldhoer, Maria
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (53) : 44234 - 44248
[25] GPR55: A novel cannabinoid receptor involved in the regulation of osteoclast function and bone mass
Whyte, L.
Ryberg, E.
Sims, N. A.
Ridge, S.
Mackie, K.
Greasley, P.
Ross, R. A.
Rogers, M. J.
BONE, 2009, 44 : S138 - S138
[26] Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
Balenga, N. A.
Martinez-Pinilla, E.
Kargl, J.
Schroeder, R.
Peinhaupt, M.
Platzer, W.
Balint, Z.
Zamarbide, M.
Dopeso-Reyes, I. G.
Ricobaraza, A.
Perez-Ortiz, J. M.
Kostenis, E.
Waldhoer, M.
Heinemann, A.
Franco, R.
BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (23) : 5387 - 5406
[27] The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
Pineiro, R.
Maffucci, T.
Falasca, M.
ONCOGENE, 2011, 30 (02) : 142 - 152
[28] Cannabinoid receptor GPR55 activation blocks nicotine use disorder by regulation of AMPAR phosphorylation
Qingqing Liu
Jiaoyan Yu
Xi Li
Yanyan Guo
Ting Sun
Li Luo
Jing Ren
Wei Jiang
Ruitao Zhang
Peng Yang
Qi Yang
Psychopharmacology, 2021, 238 : 3335 - 3346
[29] The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
Whyte, Lauren S.
Ryberg, Erik
Sims, Natalie A.
Ridge, Susan A.
Mackie, Ken
Greasley, Peter J.
Ross, Ruth A.
Rogers, Michael J.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (38) : 16511 - 16516
[30] Activation of the Novel Cannabinoid Receptor, GPR55, Mediates the Antiproliferative Effects of Anandamide on Cholangiocarcinoma Growth
Ramirez, Jonathan
Frampton, Gabriel A.
Brennan, Andrew
Huang, Li
Mohamad, Akimuddin
DeMorrow, Sharon
GASTROENTEROLOGY, 2010, 138 (05) : S792 - S792

← 1 2 3 4 5 →